Eisai President Looking To Acquire Generics Maker

Eisai is looking for a generics drug maker to acquire in an effort to build its position in the markets developing in emerging countries, President Harua Naito says. Naito said in an interview his company considers the business of generic drugs as different from that of making innovative drugs, so it would be difficult for Eisai to make the switch on its own. The company's newly opened European Knowledge Center in London affords Eisai the capacity to carry out all aspects of the drug business in a third location, in addition to current operations in Japan and the United States. (Click here for more - a subscription may be required